1276.HK
HENGRUI PHARMA
HK$58.50
-2.82%
2026-06-01
About HENGRUI PHARMA
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Key Fundamentals
P/E Ratio
46.11
Forward P/E
35.06
EPS (TTM)
HK$1.40
ROE
14.5%
Revenue Growth (YoY)
13.0%
Profit Margin
24.9%
Debt/Equity
0.10
Dividend Yield
0.3%
Price/Book
5.92
Beta
0.17
Market Cap
HK$428.43B
Avg Volume (10D)
2.1M
Recent Breakout Signals
No recent breakout signals detected for 1276.HK.
Recent Price Range (60 Days)
60D High
HK$76.75
60D Low
HK$57.25
Avg Volume
3.8M
Latest Close
HK$58.50
Get breakout alerts for 1276.HK
Sign up for Breakout Scanner to receive daily notifications when 1276.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
HENGRUI PHARMA (1276.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 1276.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 1276.HK operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.